Publications:6
- Home
- Profiles
Accepting New Patients
Mount Sinai DoctorsTreats Children
Accepting New PatientsHerbert Lazarus, MD
Pediatrics
No Patient Experience Ratings
Physician Office
212-787-1444
- About Me
- Education & Certifications
- Locations
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Education
MD, Rutgers New Jersey Medical School
Residency, Pediatrics
New York University Langone Medical Center
Fellowship, Pediatric Rheumatology
Hospital for Special Surgery
Certifications
American Board of Pediatrics
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Healthfirst Medicare Advantage insurance: Effective , Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.
- Physician Office390 West End Avenue, New York, NY, 10024
- Medicare - NJ
- Medicare - NY
- NJ Medicaid
- NY Medicaid
- United Health Care - Top Tier
- Physician Office495 Central Avenue, Suite 305, Scarsdale, NY, 10583
- Medicare - NJ
- Medicare - NY
- NJ Medicaid
- NY Medicaid
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Hepatoerythropoietic porphyria misdiagnosed as child abuse: Cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation. Julie L. Cantatore-Francis, Jessica Cohen-Pfeffer, Manisha Balwani, Philip Kahn, Herbert M. Lazarus, Robert J. Desnick, Julie V. Schaffer. Archives of Dermatology
- Cutaneous anthrax infection [4] (multiple letters). Lewis S. Nelson, Robert Hanner, Robert S. Hoffman, Mary Wu Chang, Kevin Roche, Herbert Lazarus. New England Journal of Medicine
- Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. Abigail Freedman, Olubunmi Afonja, Mary Wu Chang, Farzad Mostashari, Martin Blaser, Guillermo Perez-Perez, Herb Lazarus, Robert Schacht, Jane Guttenberg, Michael Traister, William Borkowsky. JAMA - Journal of the American Medical Association
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Lazarus has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Lazarus has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.